PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer

Judith van Loon*, Aniek J. G. Even, Hugo J. W. L. Aerts, Michel Ollers, Frank Hoebers, Wouter van Elmpt, Ludwig Dubois, Anne-Marie C. Dingemans, Roy I. Lalisang, Pascal Kempers, Boudewijn Brans, Veronique Winnepenninckx, Ernst-Jan Speel, Eric Thunnissen, Kim M. Smits, Ronald Boellaard, Danielle J. Vugts, Dirk De Ruysscher, Philippe Lambin

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)267-273
Number of pages7
JournalRadiotherapy and Oncology
Volume122
Issue number2
DOIs
Publication statusPublished - Feb 2017

Keywords

  • Zr-89-cetuximab
  • EGFR
  • Immuno-PET
  • Phase I trial
  • GROWTH-FACTOR RECEPTOR
  • MONOCLONAL-ANTIBODIES
  • PLUS CETUXIMAB
  • 1ST-LINE CHEMOTHERAPY
  • EGFR-INHIBITION
  • IMMUNO-PET
  • EXPRESSION
  • RADIOTHERAPY
  • CARCINOMA
  • SURVIVAL

Cite this

@article{58d31ff2271a4f19adfab2c44087a423,
title = "PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer",
keywords = "Zr-89-cetuximab, EGFR, Immuno-PET, Phase I trial, GROWTH-FACTOR RECEPTOR, MONOCLONAL-ANTIBODIES, PLUS CETUXIMAB, 1ST-LINE CHEMOTHERAPY, EGFR-INHIBITION, IMMUNO-PET, EXPRESSION, RADIOTHERAPY, CARCINOMA, SURVIVAL",
author = "{van Loon}, Judith and Even, {Aniek J. G.} and Aerts, {Hugo J. W. L.} and Michel Ollers and Frank Hoebers and {van Elmpt}, Wouter and Ludwig Dubois and Dingemans, {Anne-Marie C.} and Lalisang, {Roy I.} and Pascal Kempers and Boudewijn Brans and Veronique Winnepenninckx and Ernst-Jan Speel and Eric Thunnissen and Smits, {Kim M.} and Ronald Boellaard and Vugts, {Danielle J.} and {De Ruysscher}, Dirk and Philippe Lambin",
year = "2017",
month = "2",
doi = "10.1016/j.radonc.2016.11.020",
language = "English",
volume = "122",
pages = "267--273",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

PET imaging of zirconium-89 labelled cetuximab : A phase I trial in patients with head and neck and lung cancer. / van Loon, Judith; Even, Aniek J. G.; Aerts, Hugo J. W. L.; Ollers, Michel; Hoebers, Frank; van Elmpt, Wouter; Dubois, Ludwig; Dingemans, Anne-Marie C.; Lalisang, Roy I.; Kempers, Pascal; Brans, Boudewijn; Winnepenninckx, Veronique; Speel, Ernst-Jan; Thunnissen, Eric; Smits, Kim M.; Boellaard, Ronald; Vugts, Danielle J.; De Ruysscher, Dirk; Lambin, Philippe.

In: Radiotherapy and Oncology, Vol. 122, No. 2, 02.2017, p. 267-273.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - PET imaging of zirconium-89 labelled cetuximab

T2 - A phase I trial in patients with head and neck and lung cancer

AU - van Loon, Judith

AU - Even, Aniek J. G.

AU - Aerts, Hugo J. W. L.

AU - Ollers, Michel

AU - Hoebers, Frank

AU - van Elmpt, Wouter

AU - Dubois, Ludwig

AU - Dingemans, Anne-Marie C.

AU - Lalisang, Roy I.

AU - Kempers, Pascal

AU - Brans, Boudewijn

AU - Winnepenninckx, Veronique

AU - Speel, Ernst-Jan

AU - Thunnissen, Eric

AU - Smits, Kim M.

AU - Boellaard, Ronald

AU - Vugts, Danielle J.

AU - De Ruysscher, Dirk

AU - Lambin, Philippe

PY - 2017/2

Y1 - 2017/2

KW - Zr-89-cetuximab

KW - EGFR

KW - Immuno-PET

KW - Phase I trial

KW - GROWTH-FACTOR RECEPTOR

KW - MONOCLONAL-ANTIBODIES

KW - PLUS CETUXIMAB

KW - 1ST-LINE CHEMOTHERAPY

KW - EGFR-INHIBITION

KW - IMMUNO-PET

KW - EXPRESSION

KW - RADIOTHERAPY

KW - CARCINOMA

KW - SURVIVAL

U2 - 10.1016/j.radonc.2016.11.020

DO - 10.1016/j.radonc.2016.11.020

M3 - Article

VL - 122

SP - 267

EP - 273

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 2

ER -